PHARMA 4
ActiveActs, filings and financial milestones
Deadline for the 2026 accounts:
2026
01-07
abbreviated format · 30 days before the deadline
2025
02-07
full format · 29 days before the deadline
2024
31-12
Financial
Equity above €500,000equity €513,924 ▲11.3%
After 5 profitable years in a row, equity reaches €513,924.
19-07
Gazette deed
1 director appointed, 2 directors resigningResignations: Eric VANOBBERGEN (director) and Annie COENS (director) · Appointment: AWM PHARMA (director) · Permanent representative: WAHIB MOUSSA Asmaa8 points ▸
Gazette deed
1 director appointed, 2 directors resigning
Resignations: Eric VANOBBERGEN (director) and Annie COENS (director) · Appointment: AWM PHARMA (director) · Permanent representative: WAHIB MOUSSA Asmaa8 points ▸
- General meeting, 27-06-2024
- Director resignation, Eric VANOBBERGEN (director)
- Director resignation, Annie COENS (director)
- Director discharge, Eric VANOBBERGEN
- Director discharge, Annie COENS
- Director appointment, AWM PHARMA (director)
- Permanent representative, WAHIB MOUSSA Asmaa
- Board meeting, “Conseil d'Administration” (deed in French)
28-06
full format · 33 days before the deadline
2023
19-10
Gazette deed
Change of role: VANOBBERGEN Eric Jacques, from manager to directorAppointment: COENS Annie Lucy Ghislaine (director) · Amendment of the articles · Capital conversion10 points ▸
Gazette deed
Change of role: VANOBBERGEN Eric Jacques, from manager to director
Appointment: COENS Annie Lucy Ghislaine (director) · Amendment of the articles · Capital conversion10 points ▸
- General meeting, 06-10-2023
- Amendment of the articles, mentioned 2 times in the deed
- Capital conversion, “compte de capitaux propres statutairement indisponible” (deed in French)
- Kind of shares, 1000, “répartition des bénéfices et des produits de la liquidation” (deed in French)
- Director appointment, VANOBBERGEN Eric Jacques (director (not named in the articles))
- Director appointment, COENS Annie Lucy Ghislaine (director (not named in the articles))
- Director resignation, VANOBBERGEN Eric Jacques (manager)
- Other provision, “décharge au gérant démissionnaire, exécution de son mandat” (deed in French)
- Registered office clause, “1000 Bruxelles,Rue de Flandre 4” (deed in French)
- Other provision, “vote des décisions, unanimité des voix” (deed in French)
05-06
full format · 56 days before the deadline
2022
14-07
full format · 17 days before the deadline
2021
31-12
Financial
Highest result from 2018 to 2025net €115,647 ▲60.6%
The operating result of €163,806 and the net result of €115,647 are both a record.
31-12
Financial
Equity above €200,000equity €286,530 ▲46.3%
After 2 profitable years in a row, equity reaches €286,530.
25-06
full format · 36 days before the deadline
2020
31-12
Financial
Back to profitnet €71,993
The net result is €71,993, after one loss-making year.
Show earlier events
31-12
Financial
Equity above €150,000equity €195,883 ▲58.1%
Equity rises from €123,889 to €195,883.
02-06
full format · 59 days before the deadline
2019
31-12
Financial
Weakest financial yearnet -€2,597
The net result drops to -€2,597, the lowest from 2018 to 2025. It recovers the following year.
19-06
full format · 42 days before the deadline
2018
22-06
full format · 39 days before the deadline
2017
23-06
full format · 38 days before the deadline
2006
04-12
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
Sources:Publications in the Belgian Official GazetteFilings with the National Bank